転移性膵がんに対するセカンドライン治療のオプションを追加:ASCO診療ガイドラインのアップデート【JCO】

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

J Clin Oncol 2018; 36: 2545-2556

Purpose In 2016, ASCO published a guideline to assist in clinical decision making in metastatic pancreatic cancer for initial assessment after diagnosis, first- and second-line treatment options, palliative and supportive care, and follow-up. The purpose of this update is to incorporate new evidence related to second-line therapy for patients who have experienced disease progression or intolerable toxicity during first-line therapy. Methods ASCO convened an Expert Panel to conduct a systematic review of the literature on second-line therapy published between June 2015 and January 2018.

 

コメント

Leave a comment

Your email address will not be published.


*